Yeh Lab
@YehlabUNC
If we want to thoughtfully reduce NIH indirect costs, we need to reduce the federal regulatory burden that causes universities to hire so many administrators to remain compliant.
Investigators from 13 #GICancer SPOREs joined us @UNC_Lineberger this month to share findings from their SPORE-supported research. Thanks to @theNCI for helping us bring together so many brilliant minds to collaborate in one room. Together we progress! go.unc.edu/Dw2z8
Laura Peng (@itslaurapeng) and Yi Xu of the @YehlabUNC led a new @CD_AACR study mapping the tumor-intrinsic kinome landscape of #PancreaticCancer and identifying two kinotypes that differentiate basal and classical subytpes. go.unc.edu/Co5m2
🎉 Congrats to our outstanding @UNC_SOM @ConquerCancerFd awardees 🏅 Dr. @ChemtaiMungo – Career Development Award 🏅 Dr. Yash Agrawal – Young Investigator Award (YIA) 🏅 Dr. @leejae_j – YIA We’re proud to see your impactful research honored on the national stage! @UNC_Lineberger
Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: brnw.ch/21wSR0A @ASCO
Check out some highlights from the innovative #pancreaticcancer projects funded by the @UNC_Lineberger Developmental Research Program in the first two years of our @theNCI SToP Cancer SPORE grant 🔬📔 go.unc.edu/f5DCp
Excited and humbled to receive @ASCO @ConquerCancerFd YIA and thankful for mentors @YehlabUNC @Aiims1742 as well as opportunities @UNCSurgery @UNC_Lineberger
Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: brnw.ch/21wSR0A @ASCO
Online today in @Nature - our latest study led by superstar postdoc @GillesRademaker detailing the role of PSCK9 in driving sterol dependent metastatic organ choice in pancreatic cancer nature.com/articles/s4158… full text available here 👉 rdcu.be/em0VG and thread 👇
The AACR is deeply concerned that the Administration’s recent actions are threatening NIH and its mission to accelerate progress for patients with cancer and other diseases that afflict millions of Americans. We urge Congress to restore stability to NIH: brnw.ch/21wQMO3
Our PANcreatic adenocarcinoma with Gemcitabine, Erlotinib, and nAb-paclitaxel (PANGEA) trial is now recruiting #pancreaticcancer patients to test this combination treatment in advanced unresectable or metastatic basal-like subtype PDAC @theNCI @CD_AACR go.unc.edu/Aa37Y
Full policy announcement here: grants.nih.gov/grants/guide/n…
The NIH reduces its maximum indirect rate for research from 60% to 15% with immediate effect.
More than 60 leading researchers gathered at the 2025 GI SPORE Annual Investigators Meeting, hosted by UNC Lineberger, to exchange groundbreaking insights on pancreatic cancer research. This collaborative effort, supported by the GI SPORE, is driving progress toward better…
Honored to have @DrJashDatta give the @UNCSurgery James Newsome, MD professor Lecturer. Packed house, engaging and informative. The role of the neutrophil in PDAC. A lot of innovative work to move the survival needle in PDAC! @UNC_Lineberger @unc @YehlabUNC @NbmerchantMD…
🙏🙏🙏our wonderful team of nurses, nurse practitioners and navigators. Making a difference. Caring ❤️@UNC_Lineberger @UNCSurgery @UNC_Health_Care
Nurse practitioners and nurse navigators are essential to effective diagnosis and treatment of #pancreaticcancer. On #WPCD we sat for a chat w/ a few of these crucial team members who support our patients with compassion, tireless work, and vital insight: go.unc.edu/Sb53F
Thanks for spreading #PancreaticCancer awareness @UNC_PHCO.
The fighting doesn't stop.💜We’re so grateful for the amazing researchers and healthcare professionals @UNC_PHCO @UNC_Lineberger @UNC_SOM working tirelessly to improve treatment and outcomes. Together, we raise awareness, hope, and support.💪 #PancreaticCancerAwareness
In an editorial published in the @NEJM, Matthew Milowsky (@MattMilowsky), MD, FASCO, wrote that the promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment every time offers a bright future for bladder cancer patients.…
3rd, a review by @YehlabUNC on #PancreaticCancer associated fibroblasts CAFomics: convergence to translation for precision stroma approaches academic.oup.com/carcin/advance…
2024 49th Annual UNC Lineberger Comprehensive Cancer Center Trainee Day Event. Poster session: Current iTOP Trainee Kristen Gilley @UNC_Lineberger
2024 LCCC Trainee Day Event Poster Session: Current iTOP Trainee Zachary Schrank along with Honored Speaker Sean Hanlon, PhD Acting Deputy Director of the NCI Center of Strategic Scientific Initiatives (CSSI). @theNCI @UNC_Lineberger @UNCPathology
2024 49th Annual UNC Lineberger Comprehensive Cancer Center Trainee Day Event. @UNC_Lineberger
so proud of #Dr Joe Kearney giving his chief grand rounds @UNCSurgery on Mental Models 🤯🥳🥳🥳